<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran J Child Neurol</journal-id><journal-id journal-id-type="iso-abbrev">Iran J Child Neurol</journal-id><journal-id journal-id-type="publisher-id">IJCN</journal-id><journal-title-group><journal-title>Iranian Journal of Child Neurology</journal-title></journal-title-group><issn pub-type="ppub">1735-4668</issn><issn pub-type="epub">2008-0700</issn><publisher><publisher-name>Shahid Beheshti University of Medical Sciences</publisher-name><publisher-loc>Tehran, Iran</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26221158</article-id><article-id pub-id-type="pmc">4515336</article-id><article-id pub-id-type="publisher-id">ijcn-9-017</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Comparison of the Efficacy of Combination Therapy of Prednisolone - Acyclovir with Prednisolone Alone in Bell&#x02019;s Palsy</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>KHAJEH</surname><given-names>Ali</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>FAYYAZI</surname><given-names>Afshin</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>SOLEIMANI</surname><given-names>Gholamreza</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>MIRI-ALIABAD</surname><given-names>Ghasem</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>SHAYKH VEISI</surname><given-names>Sara</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>KHAJEH</surname><given-names>Behrouz</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff4">4</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Pediatrics, Children and Adolescent Health Research Center, Zahedan University of Medical Sciences, Zahedan, Iran. </aff><aff id="aff2"><label>2</label>Department of Pediatrics, Hamedan University of Medical Sciences, Hamedan, Iran. </aff><aff id="aff3"><label>3</label>General Physician, Zahedan University of Medical Sciences, Zahedan, Iran. </aff><aff id="aff4"><label>4</label>Student of Pharmacy , Zabol University of Medical Science , Zabol, Iran</aff><author-notes><corresp id="cor">Corresponding Author: Miri-Aliabad Gh. Department of Pediatrica, Children &#x00026; Adolescent Health Research Center, Zahedan University of Medical Sciences, Zahedan, Iran , Tel: + 98 5433295575 , Email: gh_miri@yahoo.com</corresp></author-notes><pub-date pub-type="ppub"><season>Spring</season><year>2015</year></pub-date><volume>9</volume><issue>2</issue><fpage>17</fpage><lpage>20</lpage><history><date date-type="received"><day>24</day><month>2</month><year>2014</year></date><date date-type="rev-recd"><day>26</day><month>1</month><year>2014</year></date><date date-type="accepted"><day>29</day><month>7</month><year>2014</year></date></history><permissions><license><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>Bell&#x02019;s palsy is a rapid onset, usually, unilateral paralysis of the facial nerve that causes significant changes in an individual&#x02019;s life such as a decline in personal, social, and educational performance. This study compared efficacy of combined prednisolone and acyclovir therapy with prednisolone alone.</p></sec><sec><title>Materials &#x00026; Methods</title><p>This study is a randomized controlled trial conducted on 43 Children (2&#x02013;18 years old) with Bell&#x02019;s palsy. The first group of 23 patients was treated with prednisolone and the remaining patients were treated with a combination of prednisolone and acyclovir. The required data were extracted, using an informational form based on the House-Brackmann Scale, which grades facial nerve paralysis. The data were analyzed with Mann-Whitney test using SPSS version 16. </p></sec><sec><title>Results</title><p>The mean age of the first and second group were 8.65 &#x000b1; 5.07 and 8.35 &#x000b1; 4.92 years, respectively, (p=0.84). Sixty one percent and 39% of patients in the first group, and 45% and 55% of patients in the second group were male and female, respectively. No significant differences exist between the groups in terms of age and gender. The rate of complete recovery was 65.2% in group I and 90% in the group II (p=0.04). </p></sec><sec><title>Conclusion</title><p>The results of this study showed that the combined prednisolone and acyclovir therapy of patients with Bell&#x02019;s palsy is far more effective than treatment with prednisolone alone. Actually, age and gender had no impact on the rate of recovery. </p></sec></abstract><kwd-group><title>Key Words</title><kwd>Bell&#x02019;s palsy</kwd><kwd>Prednisolone</kwd><kwd>Acyclovir</kwd><kwd>Children</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Introduction Bell&#x02019;s palsy is a rapid onset, idiopathic facial nerve paralysis with an incidence rate of 20 per 100,000 per year (<xref rid="B1" ref-type="bibr">1</xref>). Facial paralysis can range from mild to complete paralysis and can improve within a year (<xref rid="B2" ref-type="bibr">2</xref>). The incidence rate is equal in both genders, occurs at any age, and both sides may be affected equally (<xref rid="B3" ref-type="bibr">3</xref>). Bell&#x02019;s palsy is uncommon in children less than two years of age and a thorough examination should be performed to find out the reason for it (<xref rid="B2" ref-type="bibr">2</xref>). Despite uncertainty of the actual mechanisms of the disease and it may arise due to inflammation along the labyrinth of facial nerve bony canal that results in compression and demyelination of axon and impairment of nerve blood flow (<xref rid="B4" ref-type="bibr">4</xref>). Genetic factors, vascular ischemia, inflammatory factors secondary to viral infections, and autoimmune disorders are proposed as the underlying causes of Bell&#x02019;s palsy. However, its cause is still unknown (<xref rid="B5" ref-type="bibr">5</xref>). Many viruses, including HIV, EBV, and HBV are suspected as triggering organisms, but HSV is the most involved (<xref rid="B6" ref-type="bibr">6</xref>). The main clinical symptom of Bell&#x02019;s palsy is facial motor dysfunction (<xref rid="B5" ref-type="bibr">5</xref>). Patients complain typically about weakness or complete paralysis of all muscles on one side of the face. A lack of complete recovery of facial symmetry in the long term potentially affects the quality of life such as difficulty in drinking, eating, talking, and psychosocial problems, and creates a remarkable disruption in social activities (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B7" ref-type="bibr">7</xref>). The disease prognosis is good and almost 70% of patients recover completely within 6 months of treatment, though 30% of patients get residual symptoms, such as paresis, contracture, and face spasms or synkinesis (<xref rid="B7" ref-type="bibr">7</xref>). Treatment of these patients is controversial and variable (<xref rid="B8" ref-type="bibr">8</xref>). Prednisone and acyclovir are widely used separately or in combination; however, their effectiveness has been weakly evidenced (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>). Although there is no treatment of choice for this disease, corticosteroids are widely prescribed as the initial treatment of Bell&#x02019;s palsy to reduce swelling and inflammation of the facial nerve (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B5" ref-type="bibr">5</xref>). The effects of antiviral therapies in Bell&#x02019;s palsy are not confirmed so far and the question whether adding antiviral therapy to other treatments, such as corticosteroid therapy, can improve the disease better and faster than corticosteroids alone (<xref rid="B1" ref-type="bibr">1</xref>). Nevertheless, given the possible association of Bell&#x02019;s palsy with viral infections such as HSV, antiviral therapy seems logical (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B11" ref-type="bibr">11</xref>). This study compares the efficiency and efficacy of acyclovir, prednisolone separately; and in combination in the treatment of Bell&#x02019;s palsy in children.</p></sec><sec sec-type="materials|methods"><title>Materials &#x00026; Methods</title><p>This study was performed as a randomized controlled trial (RCT). Forty-three patients with acute unilateral peripheral facial palsy with an age range of 2&#x02013;18 years were enrolled in the study. Exclusion criteria included patients with paralysis of other cranial nerves, passing more than 3 days of symptoms onset, patients with less than 2 years of age and older than 18 years, presence of secondary causes of the 7th nerve palsy, suspicion of meningitis, vasculopathy, Ramsey Hunt syndrome, peptic ulcer, anti-herpetic treatment within the last 2 weeks, and sensitivity to acyclovir. The first group received 2 mg/ kg/day prednisolone, and the second group was treated with a combination of 2 mg/kg/day prednisolone and 10 mg/kg acyclovir every 8 hours for 7 days. In suspected cases, patients were examined to rule out other causes of the 7th nerve palsy, and imaging studies revealed a CP angle tumor in a patient with Bell&#x02019;s palsy who was then excluded from the study. Informed consent was obtained from parents of children. This study was approved by the ethics committee of the University. The required data were extracted using an informational form based on the House-Brackmann Scale (<xref rid="B12" ref-type="bibr">12</xref>), which grades facial nerve paralysis. The patients were reassessed in terms of recovery rate at the end of the first and third months of treatment. Based on the HouseBrackmann criteria, the response to treatment are graded as complete recovery (grade 1), partial recovery (grade 2&#x02013;5), and no response (grade 6). The data were analyzed using SPSS (ver 16) through comparing the efficacy of the two treatment regimens with Mann-Whitney and Fisher&#x02019;s exact tests. P-value less than 0.05 were considered significant.</p></sec><sec sec-type="results"><title>Results</title><p>
<xref ref-type="table" rid="T1">Table 1</xref> depicts the demographic characteristics of patients. Among the 43 patients with Bell&#x02019;s palsy in this study, 23 patients were treated with prednisolone and 20 patients with combination of prednisolone and acyclovir. There were no noteworthy differences in case of age and gender between the two groups (p &#x0003e; 0.05).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Frequency of Bell&#x02019;s palsy Patients according to the Age and Gender in Two Groups</p></caption><table frame="box" rules="all"><thead><tr><th style="background-color:#C2E1CD;" align="center" valign="middle" colspan="2" rowspan="1">Group</th><th style="background-color:#C2E1CD;" align="center" valign="middle" rowspan="1" colspan="1">Prednisolone group</th><th style="background-color:#C2E1CD;" align="center" valign="middle" rowspan="1" colspan="1">Combined Group</th><th style="background-color:#C2E1CD;" align="center" valign="middle" rowspan="1" colspan="1">P-Value</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="2" colspan="1">Gender</td><td align="center" valign="middle" rowspan="1" colspan="1">Male</td><td align="center" valign="middle" rowspan="1" colspan="1">14(61 %)</td><td align="center" valign="middle" rowspan="1" colspan="1">9(45%)</td><td align="center" rowspan="2" colspan="1">0.29</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Female</td><td align="center" valign="middle" rowspan="1" colspan="1">9(39% )</td><td align="center" valign="middle" rowspan="1" colspan="1">11(55% )</td></tr><tr><td align="center" valign="middle" colspan="2" rowspan="1">Mean age (yr)</td><td align="center" valign="middle" rowspan="1" colspan="1">8.65&#x000b1;5.07</td><td align="center" valign="middle" rowspan="1" colspan="1">8.35&#x000b1;4.92</td><td align="center" valign="middle" rowspan="1" colspan="1">0.84</td></tr></tbody></table></table-wrap><p>
<xref ref-type="table" rid="T2">Table 2</xref> shows the treatment results. According to this, it can be concluded that the rate of recovery in patients Comparison of the Efficacy of Combination Therapy of Prednisolone - Acyclovir with Prednisolone Alone in Bell&#x02019;s Palsy Iran J Child Neurol. 2015 Spring Vol 9 No 2 19 with Bell&#x02019;s palsy treated with combined prednisolone and acyclovir was much more than that of prednisolone therapy alone (p = 0.04) and had lower sequels after treatment.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Comparison of The Recovery Rate of Bell&#x02019;s Palsy in Prednisolone Group and Combined Treatment Group</p></caption><table frame="box" rules="all"><thead><tr><th style="background-color:#C2E1CD;" align="center" valign="middle" rowspan="1" colspan="1">P-Value</th><th style="background-color:#C2E1CD;" align="center" valign="middle" rowspan="1" colspan="1">Combined Group</th><th style="background-color:#C2E1CD;" align="center" valign="middle" rowspan="1" colspan="1">Prednisolone group</th><th style="background-color:#C2E1CD;" align="center" valign="middle" rowspan="1" colspan="1">Group</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Complete</td><td align="center" valign="middle" rowspan="1" colspan="1">15(65.2%)</td><td align="center" valign="middle" rowspan="1" colspan="1">18(90%)</td><td align="center" valign="middle" rowspan="3" colspan="1">0.04</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Partial</td><td align="center" valign="middle" rowspan="1" colspan="1">6(26.1%)</td><td align="center" valign="middle" rowspan="1" colspan="1">2(10%)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">No response</td><td align="center" valign="middle" rowspan="1" colspan="1">2(8.7%)</td><td align="center" valign="middle" rowspan="1" colspan="1">0(0%)</td></tr></tbody></table></table-wrap></sec><sec sec-type="discussion"><title>Discussion</title><p>There is no consensus on how to treat Bell&#x02019;s palsy. In our study, the rate of complete recovery was 65.2% and 90% in patients who received prednisolone alone and in those who received prednisolone and acyclovir, respectively (p = 0.04). Several studies have shown higher performance and greater improvement rate of combination therapy of prednisolone and acyclovir compared with prednisolone alone (<xref rid="B13" ref-type="bibr">13</xref>-<xref rid="B16" ref-type="bibr">16</xref>). Another study also demonstrated that patients with Bell&#x02019;s palsy who were treated with prednisolone and valacyclovir expressed better results and improvement than with any treatment (<xref rid="B17" ref-type="bibr">17</xref>). In a study by Hato et al., the recovery rate in patients treated with valacyclovir and prednisolone was higher than for patients treated with prednisolone alone. This outcome is consistent with the results of our study (<xref rid="B18" ref-type="bibr">18</xref>). Rosenblum R indicated better results were obtained when adding antiviral agents to corticosteroids for treating Bell&#x02019;s palsy (<xref rid="B19" ref-type="bibr">19</xref>). Moreover, a combination of prednisolone and famciclovir was more effective than prednisolone alone in the treatment of Bell&#x02019;s palsy and a significant number of patients improved by adding famciclovir (<xref rid="B20" ref-type="bibr">20</xref>). Adding an antivirus to the treatment of Bell&#x02019;s palsy is because of HSV involvement in facial nerve inflammation. In fact, antiviruses eradicate the virus while corticosteroid reduced nerve swelling (<xref rid="B21" ref-type="bibr">21</xref>). However, other studies that underestimate the efficacy of treatment by acyclovir as follows. In a double blind, placebo-controlled, randomized study, early treatment with prednisolone significantly improved Bell&#x02019;s palsy. However, no significant advantage was found for acyclovir alone or in combination with prednisolone (<xref rid="B22" ref-type="bibr">22</xref>). Kawagachi et al. showed that the reactivation of VZV, HSV-1 in 34% of patients with Bell&#x02019;s palsy, and the recovery rate in patients receiving combined prednisolone and valacyclovir was significantlyy greater than prednisolone alone (<xref rid="B23" ref-type="bibr">23</xref>). In a meta-analysis, results of antiviral therapy were remarkably worse than for corticosteroids (n = 768, RR 2.82, 95% CI 1.09 to 7.32), while the results of antiviral and corticosteroid therapy were significantly better than a placebo (n = 658, RR 0.56, 95% CI 0.41 to 0.76) (<xref rid="B21" ref-type="bibr">21</xref>). Meyer showed that the effect of corticosteroids in the treatment of Bell&#x02019;s palsy, despite adding antivirals, is remarkable (<xref rid="B24" ref-type="bibr">24</xref>). Another study concluded that steroids are effective in patients whose Bell&#x02019;s palsy is started recently, and that antiviral therapy does not significantly improved the facial nerve function (<xref rid="B25" ref-type="bibr">25</xref>). Numthavaj et al. inferred that the recovery rate with combination therapy increases only slightly and that prednisolone is the basis of Bell&#x02019;s palsy treatment (<xref rid="B1" ref-type="bibr">1</xref>). As maintained by the results of this study and other similar studies, combination therapy, especially in severe cases of Bell&#x02019;s palsy, is more effective than prednisolone alone and results in more complete recovery of facial paralysis and reduction of its complications. However, some studies have not indicated further merits for adding antiviral agents to corticosteroids. This could be due to several factors. Also, our study was different in consumption of antiviral agents, sample size, patient age, and different inclusion and exclusion criteria in comparison of other studies. </p></sec></body><back><ack><title>Acknowledgment</title><p>The authors wish to thank all patients participated in this study as well as all nurses in the pediatric ward.</p></ack><sec><title/><p>
<bold>Conflict of interest:</bold> the authors have nothing to disclose.</p></sec><sec><title>Author Contribution</title><p>Ali Khajeh: Study concepts and design, Gholamreza Soleimani: Literature search, Ghasem Miri-Aliabad: Clinical studies, Data analysis. Statistical analysis, Manuscript preparation. Afshin Fayazi: Manuscript editing, Sara Shaykh Veisi: Data acquisition,Behrooz Khajeh: Manuscript review.</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Numthavaj</surname><given-names>P</given-names></name><name><surname>Thakkinstian</surname><given-names>A</given-names></name><name><surname>Dejthevaporn</surname><given-names>CH</given-names></name><etal/></person-group><article-title>Corticosteroid and antiviral therapy for Bell&#x02019;s palsy: A network meta-analysis</article-title><source> BMC Neurology</source><year>2011</year><volume>11</volume><fpage>1</fpage><pub-id pub-id-type="pmid">21208452</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atzema</surname><given-names>C</given-names></name><name><surname>Goldman</surname><given-names>RD</given-names></name></person-group><article-title>Should we use steroids to treat children with Bell&#x02019;s palsy?</article-title><source> Can Fam Physician </source><year>2006</year><volume>52</volume><issue>3</issue><fpage>313</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">16572574</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiemstra</surname><given-names>JD</given-names></name><name><surname>Khatkhate</surname><given-names>N</given-names></name></person-group><article-title>Bell&#x02019;s Palsy: Diagnosis and Management</article-title><source> Am Fam Physician</source><year>2007</year><volume>76</volume><issue>7</issue><fpage>997</fpage><lpage>1002</lpage><pub-id pub-id-type="pmid">17956069</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>CG</given-names></name><name><surname>von</surname><given-names>Doersten PG</given-names></name></person-group><article-title>The facial nerve: Current trends in diagnosis, treatment, and rehabilitation</article-title><source>Med Clin North Am</source><year>1999</year><volume>83</volume><fpage>179</fpage><lpage>195</lpage><pub-id pub-id-type="pmid">9927969</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>John</surname><given-names>K</given-names></name><name><surname>Goudakos</surname><given-names>JK</given-names></name><name><surname>Markou</surname><given-names>KD</given-names></name><etal/></person-group><article-title>Corticosteroids vs Corticosteroids Plus Antiviral Agents in the Treatment of Bell Palsy</article-title><source> Arch Otolaryngol Head Neck Surg</source><year>2009</year><volume>135</volume><issue>6</issue><fpage>558</fpage><lpage>564</lpage><pub-id pub-id-type="pmid">19528403</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>de Araujo M</given-names></name><name><surname>Rodrigues</surname><given-names>Azenha M</given-names></name><name><surname>Capelari</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Management of Bell&#x02019;s Palsy: A Report of 2 Cases</article-title><source> jcda</source><year>2008</year><volume>74</volume><issue>9</issue><fpage>823</fpage><pub-id pub-id-type="pmid">19000467</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>JI</given-names></name><name><surname>Lee</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Acupuncture for sequelae of Bell&#x02019;s palsy: a randomized controlled trial protocol</article-title><source> Trials</source><year>2011</year><volume>12</volume><fpage>71</fpage><pub-id pub-id-type="pmid">21388554</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williamson</surname><given-names>IG</given-names></name><name><surname>Whelan</surname><given-names>TR</given-names></name></person-group><article-title>The clinical problem of Bell&#x02019;s palsy: is treatment with steroids effective? </article-title><source>Br J Gen Pract </source><year>1996</year><volume>46</volume><fpage>743</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">8995858</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grogan</surname><given-names>PM</given-names></name><name><surname>Gronseth</surname><given-names>GS</given-names></name></person-group><article-title>Practice parameter: steroids, acyclovir, and surgery for Bell&#x02019;s palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology</article-title><source> Neurology</source><year>2001</year><volume>56</volume><fpage>830</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11294918</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowlands</surname><given-names>S</given-names></name><name><surname>Hooper</surname><given-names>R</given-names></name><name><surname>Hughes</surname><given-names>R</given-names></name><name><surname>Burney</surname><given-names>P</given-names></name></person-group><article-title>The epidemiology and treatment of Bell&#x02019;s palsy in the UK</article-title><source> Eur J Neurol</source><year>2002</year><volume>9</volume><fpage>63</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11784378</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holland</surname><given-names>NJ</given-names></name><name><surname>Weiner</surname><given-names>GM</given-names></name></person-group><article-title>Recent developments in Bell&#x02019;s palsy</article-title><source> BMJ</source><year>2004</year><volume>329</volume><issue>7465</issue><fpage>553</fpage><lpage>557</lpage><pub-id pub-id-type="pmid">15345630</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>House</surname><given-names>JW</given-names></name><name><surname>Brackmann</surname><given-names>DE</given-names></name></person-group><article-title>Facial nerve grading system</article-title><source> Otolaryngol Head Neck Surg</source><year>1985</year><volume>93</volume><fpage>146</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">3921901</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thaera</surname><given-names>GM</given-names></name><name><surname>Wellik</surname><given-names>KE</given-names></name><name><surname>Barrs</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Are corticosteroid and antiviral treatments effective for bell palsy? A critically appraised topic</article-title><source> Neurologist</source><year>2010</year><volume>16</volume><issue>2</issue><fpage>138</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">20220455</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hato</surname><given-names>N</given-names></name><name><surname>Matsumoto</surname><given-names>S</given-names></name><name><surname>Kisaki</surname><given-names>H</given-names></name><etal/></person-group><article-title>Efficacy of early treatment of Bell&#x02019;s palsy with oral acyclovir and prednisolone</article-title><source> Otol Neurotol</source><year>2003</year><volume>24</volume><fpage>948</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">14600480</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahangar</surname><given-names>AA</given-names></name><name><surname>Hosseini</surname><given-names>S</given-names></name><name><surname>Saghebi</surname><given-names>R</given-names></name></person-group><article-title>Comparison of the efficacy of prednisolone versus prednisolone and acyclovir in the treatment of Bell`s palsy</article-title><source> Neurosciences (Riyadh)</source><year>2006</year><volume>11</volume><issue>4</issue><fpage>256</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">22266433</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HY</given-names></name><name><surname>Byun</surname><given-names>JY</given-names></name><name><surname>Park</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Steroid-antiviral treatment improves the recovery rate in patients with severe Bell&#x02019;s palsy</article-title><source> Am J Med</source><year>2013</year><volume>126</volume><issue>4</issue><fpage>336</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">23394867</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Axelsson</surname><given-names>S</given-names></name><name><surname>Lindberg</surname><given-names>S</given-names></name><name><surname>Stjernquist-Desatnik</surname><given-names>A</given-names></name></person-group><article-title>Outcome of treatment with valacyclovir and prednisone in patients with Bell&#x02019;s palsy</article-title><source> Ann Otol Rhinol Laryngol</source><year>2003</year><volume>112</volume><issue>3</issue><fpage>197</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">12656408</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hato</surname><given-names>N</given-names></name><name><surname>Yamada</surname><given-names>H</given-names></name><name><surname>Kohno</surname><given-names>H</given-names></name><etal/></person-group><article-title>Valacyclovir and prednisolone treatment for Bell&#x02019;s palsy: a multicenter, randomized, placebo-controlled study</article-title><source> Otol Neurotol</source><year>2007</year><volume>28</volume><fpage>408</fpage><lpage>413</lpage><pub-id pub-id-type="pmid">17414047</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenblum</surname><given-names>R</given-names></name></person-group><article-title>Combination Treatments for Bell Palsy Can Provide Clinical Benefit</article-title><source> The Journal of the American Dental Association</source><year>2010</year><volume>141</volume><issue>3</issue><fpage>330</fpage><lpage>331</lpage><pub-id pub-id-type="pmid">20194389</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahidullah</surname><given-names>M</given-names></name><name><surname>Haque</surname><given-names>A</given-names></name><name><surname>Islam</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Comparative study between combination of famciclovir and prednisolone with prednisolone alone in acute Bell&#x02019;s palsy</article-title><source> Mymensingh Med J</source><year>2011</year><volume>20</volume><issue>4</issue><fpage>605</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">22081178</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lockhart</surname><given-names>P</given-names></name><name><surname>Daly</surname><given-names>F</given-names></name><name><surname>Pitkethly</surname><given-names>M</given-names></name><etal/></person-group><article-title>Antiviral treatment for Bell&#x02019;s palsy (idiopathic facial paralysis)</article-title><source> Cochrane Database Syst Rev</source><year>2009</year><issue>4</issue><fpage>CD001869</fpage><pub-id pub-id-type="pmid">19821283</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>FM</given-names></name><name><surname>Swan</surname><given-names>IRC</given-names></name><name><surname>Donnan</surname><given-names>PT</given-names></name><etal/></person-group><article-title>Early Treatment with Prednisolone or Acyclovir in Bell&#x02019;s palsy</article-title><source> N Engl J Med</source><year>2007</year><volume>357</volume><fpage>1598</fpage><lpage>1607</lpage><pub-id pub-id-type="pmid">17942873</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawaguchi</surname><given-names>K</given-names></name><name><surname>Inamura</surname><given-names>H</given-names></name><name><surname>Abe</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell&#x02019;s palsy</article-title><source> Laryngoscope</source><year>2007</year><volume>117</volume><issue>1</issue><fpage>147</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">17202945</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>MW</given-names></name><name><surname>Hahn</surname><given-names>CH</given-names></name></person-group><article-title>Treatment of idiopathic peripheral facial nerve paralysis (Bell&#x02019;s palsy)</article-title><source> Ugeskr Laeger</source><year>2013</year><month>1</month><volume>175</volume><issue>5</issue><fpage>275</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">23369330</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gronseth</surname><given-names>GS</given-names></name><name><surname>Paduga</surname><given-names>R</given-names></name></person-group><article-title>Evidence-based guideline update: steroids and antivirals for Bell palsy: report of the Guideline Development Subcommittee of the American Academy of Neurology</article-title><source> American Academy of Neurology</source><year>2012</year><volume>79</volume><issue>22</issue><fpage>2209</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">23136264</pub-id></element-citation></ref></ref-list></back></article>